Preclinical diagnosis of Alzheimer's disease (AD) is one of the major challenges for the prevention of AD. AD biomarkers are needed not only to reveal preclinical pathologic changes, but also to monitor progression and therapeutics. PET neuroimaging can reliably assess aspects of the molecular biology and neuropathology of AD. The aim of this article is to review the use of FDG-PET and amyloid PET imaging in the early detection of AD.
Early detection of Alzheimer's disease with PET imaging / Berti V;Osorio RS;Mosconi L;Li Y;De Santi S;de Leon MJ. - In: NEURODEGENERATIVE DISEASES. - ISSN 1660-2854. - ELETTRONICO. - 7:(2010), pp. 131-135. [10.1159/000289222]
Early detection of Alzheimer's disease with PET imaging.
BERTI, VALENTINA;
2010
Abstract
Preclinical diagnosis of Alzheimer's disease (AD) is one of the major challenges for the prevention of AD. AD biomarkers are needed not only to reveal preclinical pathologic changes, but also to monitor progression and therapeutics. PET neuroimaging can reliably assess aspects of the molecular biology and neuropathology of AD. The aim of this article is to review the use of FDG-PET and amyloid PET imaging in the early detection of AD.
| File | Dimensione | Formato | |
|---|---|---|---|
|
NeurodegenerativeDis_2010_early_detection_AD.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
162.48 kB
Formato
Adobe PDF
|
162.48 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
